Bofill, JS; Anton, FM; Sanchez, CAR; Calvo, EG; Melia, CH; Gil, EMC; Vidal, M; Jimenez-Rodriguez, B; Merino, LD; Janez, NM; Vazquez, RV; Salas, RD; Torres, AA; Lopez, IMA; Gregori, JG; Garcia, VQ; Rubio, EV; De la Haba-Rodriguez, J; Gonzalez-Santiago, S; Fernandez, ND; Molins, AB; De Ibarguen, BCS; Mingorance, JID; Ezquerra, MB; De Casa, S; Gimeno, A; Martin, M – 2022
Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2-advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial
por prodriguez | Ene 1, 2022 | Publicaciones - CIMO-01 | 0 Comentarios